BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19526354)

  • 1. Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization.
    Sparano JA; Hortobagyi GN; Gralow JR; Perez EA; Comis RL
    Breast Cancer Res Treat; 2010 Feb; 119(3):511-27. PubMed ID: 19526354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups.
    O'Dwyer PJ; Eckhardt SG; Haller DG; Tepper J; Ahnen D; Hamilton S; Benson AB; Rothenberg M; Petrelli N; Lenz HJ; Diasio R; DuBois R; Sargent D; Sloan J; Johnson CD; Comis RL; O'Connell MJ;
    J Clin Oncol; 2007 Jun; 25(16):2313-21. PubMed ID: 17538178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Trials: A Congressional Focus of Need.
    Coltman CA
    Oncologist; 1997; 2(4):VII-VIII. PubMed ID: 10388059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations.
    Thuerlimann B; Koeberle D; Senn HJ
    Eur J Cancer; 2007 Jan; 43(1):46-52. PubMed ID: 17085045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
    Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
    J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
    Peppercorn J; Blood E; Winer E; Partridge A
    Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
    Moreno-Aspitia A; Perez EA
    Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer prevention clinical trials.
    Greenwald P
    J Clin Oncol; 2002 Sep; 20(18 Suppl):14S-22S. PubMed ID: 12235220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Operable breast cancer without axillary node involvement: current therapeutic concepts].
    Piccart MJ
    Rev Med Brux; 1989 Dec; 10(10):424-31. PubMed ID: 2690264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in adjuvant therapy for breast cancer.
    Slamon DJ; Romond EH; Perez EA;
    Clin Adv Hematol Oncol; 2006 Mar; 4(3 Suppl 7):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10. PubMed ID: 16736568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of biology and prevention in aerodigestive tract cancers.
    Greenwald P; Stern HR
    J Natl Cancer Inst Monogr; 1992; (13):3-14. PubMed ID: 1389693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ; McKinney MM; Carpenter WR
    Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperatives.
    Anderson BD; Adamson PC; Weiner SL; McCabe MS; Smith MA
    J Clin Oncol; 2004 Dec; 22(23):4846-50. PubMed ID: 15570088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trials of high-dose chemotherapy in breast cancer: fraud, the press and the data (or lessons learned in medical policy governing clinical research).
    Antman K
    Trans Am Clin Climatol Assoc; 2002; 113():56-66; discussion 66-7. PubMed ID: 12053718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.
    Sparano JA; Pisano ED; White JR; Hunt KK; Mamounas EP; Perez EA; Hortobagyi GN; Gralow JR; Comis RL
    Breast Cancer Res Treat; 2010 Apr; 120(2):273-84. PubMed ID: 20024613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.